China's Landwind Device Maker Reported Target Of U.S. Acquisition
This article was originally published in PharmAsia News
Executive Summary
Chinese medical-device maker Landwind is said to be the target of an acquisition effort by the U.S.-based hedge fund, Avenue Capital